(Which is to say, this may be a story of more consumers spending less money at Hims & Hers.) Accentuating the positive, though, CEO Andrew Dudum insisted Hims & Hers is "not just growing, we're pulling away from the field on our path to becoming the world's largest consumer health platform." More than just adding customers, Hims & Hers is entering new markets, expanding into new drug categories, and focusing on "comprehensive diagnostics" to help differentiate itself as a provider of personalized healthcare
Clinical implications of estimated glomerular filtration rate dip following sodiumglucose cotransporter-2 inhibitor initiation on cardiovascular and kidney outcomes
American College of Rheumatology
Lymphokine regulation of HLA-DR gene expression in human thyroid cell monolayers
This suggests GLP-1 receptor activation in the brain may have secondary anti-inflammatory and thermoregulatory benefits independent of appetite suppression
These treatments also work alongside testosterone replacement therapy (TRT) and medical weight loss program, including GLP-1s, helping support energy, metabolism, and sustainable weight management as part of a comprehensive approach to wellness